Norden Group LLC Medpace Holdings, Inc. Transaction History

Norden Group LLC

$984 Billion
Q3 2025

A detailed history of Norden Group LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Norden Group LLC holds 1,234 shares of MEDP stock, worth $721,778. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,234

Previous 1,122 9.98%

Holding current value

$721,778

Previous $352 Million 80.17%

% of portfolio

0.06%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$308.88 - $514.16 $34,594 - $57,585	112 Added 9.98%	1,234 $634 Million
Q2 2025 Jul 15, 2025	SELL	$277.23 - $315.28 $122,258 - $139,038	-441 Reduced 28.21%	1,122 $352 Million
Q1 2025 May 07, 2025	SELL	$304.69 - $360.97 $465,261 - $551,201	-1,527 Reduced 49.42%	1,563 $476 Million
Q4 2024 Feb 05, 2025	BUY	$308.93 - $363.58 $8,650 - $10,180	28 Added 0.91%	3,090 $1.03 Billion
Q3 2024 Oct 17, 2024	SELL	$320.58 - $457.29 $99,059 - $141,302	-309 Reduced 9.17%	3,062 $1.02 Billion
Q2 2024 Aug 06, 2024	BUY	$372.0 - $424.34 $260,772 - $297,462	701 Added 26.25%	3,371 $1.39 Billion
Q1 2024 Apr 30, 2024	SELL	$284.87 - $413.31 $7.64 Million - $11.1 Million	-26,810 Reduced 90.94%	2,670 $1.08 Billion
Q1 2024 Apr 19, 2024	BUY	$284.87 - $413.31 $6.97 Million - $10.1 Million	24,466 Added 487.95%	29,480 $11.9 Billion
Q4 2023 Feb 05, 2024	BUY	$227.52 - $312.68 $770,155 - $1.06 Million	3,385 Added 207.8%	5,014 $1.54 Billion
Q3 2023 Nov 06, 2023	BUY	$233.98 - $281.67 $381,153 - $458,840	1,629 New	1,629 $394 Million

Others Institutions Holding MEDP

# of Institutions

683

Shares Held

27M

Call Options Held

53.6K

Put Options Held

108K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $18.2B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.

Account